TP53 Gene Alterations including Codon 72 Polymorphism in Patients with Multiple Myeloma

Journal Title: Journal of Clinical and Diagnostic Research - Year 2018, Vol 12, Issue 2

Abstract

ABSTRACT Introduction: Multiple Myeloma (MM) is a cytogenetically heterogeneous haematologic malignancy characterised by uncontrolled proliferation of clonal plasma cells within the bone marrow. TP53 gene inactivation is considered as an independent prognostic marker and patients harbouring these mutations are usually resistant to standard therapy. Aim: To determine the frequency of TP53 gene mutations in exons 4 to 9 and the distribution of Arg72Pro polymorphism in exon 4 in newly diagnosed multiple myeloma patients. Materials and Methods: Mutation analysis of genomic DNA from unsorted bone marrow aspirates of 30 patients (10 showed TP53 deletion by interphase FISH) and from peripheral blood lymphocytes of 30 healthy control individuals was performed by direct sequencing of amplified products using self-designed primers. The codon 72 polymorphism was studied using Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) technique in an additional 108 MM patients and 70 healthy controls. Results: TP53 gene alterations were recorded in six patients (20%) and three of them showed two or more changes. No alterations were observed in exons 5, 7 and 9 in myeloma patients. Four mutations in codons c.284C>T (exon 4), c.641A>G (exon 6), c.787A>G and c.808T>G (exon 8) and three intronic variants c.672+48G>A (intron 6), c.782+72C>T and c.782+92T>G (intron 7) were seen only in the patient group. The variants c.108G>A (exon 4), c.672+62A>G (intron 6) and c.993+12T>C (intron 9) were observed in both groups. Three patients died within six months of diagnosis. The genotype and allele frequencies for Arg72Pro polymorphism were similar in the patient and in the control groups. Conclusion: The presence of TP53 mutations denoted a poor prognosis while the TP53 Pro72Arg polymorphism is not associated with increased risk for MM.

Authors and Affiliations

Perumal Govindasamy, Charles Sharchil, Nithya Mohan, Prabu Pandurangan, Anil Tarigopula, Rama Mani, Chandra R Samuel

Keywords

Related Articles

Performance of Disease-Specific Scoring Models in Intensive Care Patients with Severe Liver Diseases

Introduction: Egypt has the highest prevalence of Hepatitis C Virus (HCV) in the world, estimated nationally at 14.7%. HCV treatment consumes 20% ($80 million) of Egypt’s annual health budget. Outcomes of cirrhotic patie...

Is Low Cholesterol a Predisposing Factor for Primary Intracerebral Haemorrhage? A South Indian Perspective

ABSTRACT Introduction: Stroke is an important cause of mortality and morbidity in low-income and middle-income countries like India. Primary Intracerebral Haemorrhage (PICH) refers to Intracerebral Haemorrhage (ICH) in t...

Career Satisfaction among Dental Public Health Specialists in India – A Cross-sectional Survey

for the growth of the discipline and the profession. An empirical investigation of satisfaction in career and amendments needed in course and profession may help in growth of discipline. Aim: To assess career satisfactio...

Prediction of Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) after Thoracic Surgery: The Role of Estimated GFR

Introducton: Little is known about the prognostic utility of preoperative estimated GFR (eGFR) on perioperative Major Adverse Cardiovascular and Cerebrovascular Events (MACCE) in apparently lower risk patients undergoing...

Cytological Study of Abdominal Lymph Nodes by Fine Needle Aspiration under Image Guidance

ABSTRACT Introduction: Fine Needle Aspiration Cytology (FNAC) has become simple, safe, speedy, cost-effective, accurate and more diagnostic after advancement in imaging techniques. Sensitivity of image guided FNAC of int...

Download PDF file
  • EP ID EP511741
  • DOI 10.7860/JCDR/2018/34222.11170
  • Views 67
  • Downloads 0

How To Cite

Perumal Govindasamy, Charles Sharchil, Nithya Mohan, Prabu Pandurangan, Anil Tarigopula, Rama Mani, Chandra R Samuel (2018). TP53 Gene Alterations including Codon 72 Polymorphism in Patients with Multiple Myeloma. Journal of Clinical and Diagnostic Research, 12(2), 1-5. https://europub.co.uk/articles/-A-511741